MAPK8 and lung carcinoma: In our experiments, by using CXCR2 inhibitor SBB225002, CXCLs/CXCR2 axis was found to promoted lung cancer cells proliferation and EMT, and inhibited lung cancer cells apoptosis and senescence via p38/ERK, not JNK, MAPK pathway.